Earnings To Watch: Aytu BioPharma Inc (AYTU) Reports Q2 2026 Result [Yahoo! Finance]
Aytu BioPharma, Inc. (AYTU)
NASDAQ:AMEX Investor Relations:
aytubio.com/investors/stock-information
Company Research
Source: Yahoo! Finance
The consensus estimate for Q2 2026 revenue is $12.17 million, and the earnings are expected to come in at -$0.49 per share. The full year 2026's revenue is expected to be $55.26 million and the earnings are expected to be -$1.01 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 9 Warning Signs with AYTU. Is AYTU fairly valued? Test your thesis with our free DCF calculator. Over the past 90 days, revenue estimates for Aytu BioPharma Inc ( NASDAQ:AYTU ) have declined from $55.86 million to $55.26 million for the full year 2026, while estimates for 2027 have increased from $72.13 million to $81.41 million. Additionally, earnings estimates have improved from -$1.37 per share to -$1.01 per share for the full year 2026, and from -$0.42 per share to -$0.28 per share for 2027. In the previous quarter of 2025-09-30, Aytu BioPharma Inc's ( NASDAQ:AYTU ) actual revenue was $13.89 million, which beat analysts' revenue expectations of
Show less
Read more
Impact Snapshot
Event Time:
AYTU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AYTU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AYTU alerts
High impacting Aytu BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
AYTU
News
- Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026 [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript [Seeking Alpha]Seeking Alpha
- Aytu BioPharma (NASDAQ:AYTU) had its price target raised by analysts at Ascendiant Capital Markets from $12.50 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- Aytu BioPharma (NASDAQ:AYTU) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ... [Yahoo! Finance]Yahoo! Finance
AYTU
Analyst Actions
- 12/10/25 - Ascendiant Capital
AYTU
Sec Filings
- 1/20/26 - Form 8-K
- 12/10/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- AYTU's page on the SEC website